Joint Corp reports results for the quarter ended September 30 - Earnings Summary
Joint Corp reports results for the quarter ended September 30 - Earnings Summary
Joint Corp JYNT.OQ reported quarterly adjusted earnings of 10 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 2 cents. The mean expectation of four analysts for the quarter was for earnings of 8 cents per share. Wall Street expected results to range from 3 cents to 12 cents per share.
Revenue rose 1.3% to $13.55 million from a year ago; analysts expected $14.85 million.
Joint Corp's reported EPS for the quarter was a loss of 1 cent.
The company reported a quarterly loss of $117 thousand.
Joint Corp shares had risen by 1.5% this quarter and lost 13.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Joint Corp is $9.00, about 18.1% above its last closing price of $7.37
This summary was machine generated from LSEG data November 6 at 01:57 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.08 | 0.10 | Beat |
Jun. 30 2026 | 0.05 | -0.01 | Missed |
Mar. 31 2026 | 0.03 | 0.08 | Beat |
Dec. 31 2025 | 0.04 | 0.07 | Beat |
Recent news on Joint
See all newsJoint Corp reports results for the quarter ended September 30 - Earnings Summary
Joint Q3 revenue misses analyst expectations
Brief: Joint Q3 EPS USD -0.01
Brief: Joint Corp To Reacquire Texas Regional Development Rights And Terminate Related Agreements
Brief: Joint Corp. To Close Underperforming Clinics In 2026